beyond the ai hype: 'real' ai in cmc
from scientific excellence to real-world value
A science-first, real-world session focused on where artificial intelligence can create meaningful value across CMC.
Co-chaired by Kevin J. Bittorf and Paul Kirchoff, the session combines Kevin’s CMC development, manufacturing and outsourcing perspective with Paul’s AI transformation and value-creation lens. Together, they will challenge where AI can improve scientific decisions, workflows and measurable outcomes - and where it cannot.
who you'll meet
✓ CMC and Scientific Leaders across Drug Substance and Drug Product
✓ Manufacturing, Technical Operations, MS&T, QC and Quality Leaders
✓ Process Development, Formulation and Data/Automation Experts
✓ Biotech, Pharma and CDMO leaders working to turn AI into CMC value
opening
Scene-setting introduction from Kevin Bittorf and Paul Kirchoff: where AI is entering CMC, what scientific and operational problems are worth solving, and how the Live Lab will separate practical value from AI noise.
AI IN CMC
Scientific-leader panel focused on where AI can create meaningful value across drug substance & product, analytical, manufacturing/MS&T, and Quality. Where is AI useful today, where are expectations ahead of reality, and which problems matter most?
AI IN THE REAL WORLD
Real-world CMC examples - not AI theory. Users and operators show actual applications: the problem, the data and AI approach, how it fits into the workflow, what decision or output it supports, what value was created, and what was learned.
SCIENTIFIC BUSINESS CASE
Connect scientific excellence to measurable value. Explore when an AI application becomes worth funding through faster development, fewer experiments, improved yield, stronger investigations, batch success, faster release, capacity, tech-transfer speed, and scientist productivity.
Learn more about the Oral Drug Delivery Live Lab happening on Thursday, December 10th, 2026.
